SVTP and Incidence of Cancer: Patient Follow-up and Outcomes
| SVTP Patients | Control Group | ||||
|---|---|---|---|---|---|
| Follow-up and Outcome | No. (%) | 95% CI | No. (%) | 95% CI | Absolute Difference % (95% CI) |
| CI=confidence interval; NA = not applicable; SVTP = superficial venous thrombophlebitis. | |||||
| Patients with incomplete follow-up | 34 (12) | 8–16 | 84 (15) | 12–18 | −3 (−8 to 2) |
| Deaths within 24 months after index date | 16 (6) | 3–9 | 19 (3) | 2–5 | 2 (−1 to 5) |
| Patients with newly diagnosed cancer within 24 months after index date | 5 (2) | 1–5 | 10 (2) | 1–4 | 0 (−2 to 2) |
| Recurrent SVTP in patients without cancer at study entry | 18 (7) | 4–11 | NA | NA | NA |